DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Pfisterer J et al.
Gemcitabine plus carboplatin compared with carboplatin in patients with
platinum-sensitive recurrent ovarian cancer: an intergroup trial of the
AGO-OVAR, the NCIC CTG, and the EORTC GCG.
J Clin Oncol 2006;
24: 4699-4707
We do not assume any responsibility for the contents of the web pages of other providers.